Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
Sow Good
- The Trade: Sow Good Inc. (OTC: SOWG) Director Lyle Berman acquired a total of 68,966 shares an average price of $7.25. To acquire these shares, it cost around $500,004.
- What’s Happening: On March 28, Sow Good announced a $3.7 million private placement.
- What Sow Good Does: Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups.
- The Trade: Oncternal Therapeutics, Inc. (NASDAQ: ONCT) Director Robert James Wills acquired a total of 6,914 shares at an average price of $8.48. To acquire these shares, it cost around $58,602.
- What’s Happening: On March 7, Oncternal Therapeutics posted upbeat quarterly sales.
- What Oncternal Therapeutics Does: Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need.
Westlake Chemical Partners
- The Trade: Westlake Chemical Partners LP (NYSE: WLKP) SVP, Olefin Material & Corp Pr Andrew Kenner bought a total of 5,000 shares at an average price of $22.23. To acquire these shares, it cost around $111,150.
- What’s Happening: On Feb. 20, Westlake Chemical posted downbeat quarterly results.
- What Westlake Chemical Partners Does: Westlake Chemical Partners LP is a part of the chemical industry in the United States.
Check This Out: Dave & Buster's Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.